natgillin/translations-raw huggingface dataset:
Where high levels of maternal antibodies against rhinotracheitis or calicivirosis components are expected to be present (e.g. in kittens of 9–12 weeks of age borne from queens, which were vaccinated before pregnancy and/or with known or suspected previous exposure to the pathogen(s)), the primary vaccination course should be delayed until 12 weeks of age.
Kjer je pričakovati visoke titre maternalnih protiteles proti komponentam rinotraheitisa ali kalicivoze (na primer pri mladičih starih od 9 do 12 tednov, rojenih mačkam, ki so bile cepljene pred brejostjo in/ali je znano ali verjetno, da so bile predhodno izpostavljene patogenu (om)), je potrebno osnovno cepljenje odložiti do starosti 12 tednov.
Where high levels of maternal antibodies against rhinotracheitis, calicivirosis or panleucopenia components are expected to be present (e.g. in kittens of 9–12 weeks of age born from queens which were vaccinated before pregnancy and/or with known or suspected previous exposure to the pathogen(s)), the primary vaccination course should be delayed until 12 weeks of age.
Kjer je pričakovati visoke titre maternalnih protiteles proti komponentam rinotraheitisa, kalici viroze ali panleukopenije (na primer pri mladičih starih od 9 do 12 tednov, rojenih mačkam, ki so bile cepljene pred brejostjo in/ali je znano ali verjetno, da so bile predhodno izpostavljene patogenu (om)), je potrebno osnovno cepljenje odložiti do starosti 12 tednov.
Where high levels of maternal antibodies against rhinotracheitis, calicivirosis or panleucopenia components are expected to be present (e.g. in kittens of 9–12 weeks of age born from queens, which were vaccinated before pregnancy and/or with known or suspected previous exposure to the pathogen(s)), the primary vaccination course should be delayed until 12 weeks of age.
Kjer je pričakovati visoke titre maternalnih protiteles proti komponentam rinotraheitisa, kaliciviroze ali panleukopenije (na primer pri mladičih starih od 9 do 12 tednov, rojenih mačkam, ki so bile cepljene pred brejostjo in/ali je znano ali verjetno, da so bile predhodno izpostavljene patogenu (om)), je potrebno osnovno cepljenje odložiti do starosti 12 tednov.
Where high levels of maternal antibodies against rhinotracheitis, calicivirosis or panleucopenia components are expected to be present (e.g. in kittens of 9–12 weeks of age borne from queens which were vaccinated before pregnancy and/or with known or suspected previous exposure to the pathogen(s)), the primary vaccination course should be delayed until 12 weeks of age.
Kjer je pričakovati visoke titre maternalnih protiteles proti komponentam rinotraheitisa, kaliciviroze ali panleukopenije (na primer pri mladičih starih od 9 do 12 tednov, rojenih mačkam, ki so bile cepljene pred brejostjo in/ali je znano ali verjetno, da so bile predhodno izpostavljene patogenu (om)), je potrebno osnovno cepljenje odložiti do starosti 12 tednov.
Where high levels of maternal antibodies against rhinotracheitis, calicivirosis, panleucopenia or Chlamydophila components are expected to be present (e.g. in kittens of 9–12 weeks of age born from queens which were vaccinated before pregnancy and/or with known or suspected previous exposure to the pathogen(s)), the primary vaccination course should be delayed until 12 weeks of age.
Kjer je pričakovati visoke titre maternalnih protiteles proti komponentam rinotraheitisa, kaliciviroze, panleukopenije ali Chlamydophile (na primer pri mladičih starih od 9 do 12 tednov, rojenih mačkam, ki so bile cepljene pred brejostjo in/ali je znano ali verjetno, da so bile predhodno izpostavljene patogenu (om)), je potrebno osnovno cepljenje odložiti do starosti 12 tednov.
Where high levels of maternal antibodies against rhinotracheitis, calicivirosis, panleucopenia or Chlamydophila components are expected to be present (e.g. in kittens of 9–12 weeks of age born from queens, which were vaccinated before pregnancy and/or with known or suspected previous exposure to the pathogen(s)), the primary vaccination course should be delayed until 12 weeks of age.
Kjer je pričakovati visoke titre maternalnih protiteles proti komponentam rinotraheitisa, kaliciviroze, panleukopenije ali Chlamydophile (na primer pri mladičih starih od 9 do 12 tednov, rojenih mačkam, ki so bile cepljene pred brejostjo in/ali je znano ali verjetno, da so bile predhodno izpostavljene patogenu (om)), je potrebno osnovno cepljenje odložiti do starosti 12 tednov.
Where high levels of maternal antibodies against rhinotracheitis, calicivirosis, panleucopenia or Chlamydophila components are expected to be present (e.g. in kittens of 9–12 weeks of age borne from queens which were vaccinated before pregnancy and/or with known or suspected previous exposure to the pathogen(s)), the primary vaccination course should be delayed until 12 weeks of age.
Kjer je pričakovati visoke titre maternalnih protiteles proti komponentam rinotraheitisa, kaliciviroze, panleukopenije ali Chlamydophile (na primer pri mladičih starih od 9 do 12 tednov, rojenih mačkam, ki so bile cepljene pred brejostjo in/ali je znano ali verjetno, da so bile predhodno izpostavljene patogenu (om)), je potrebno osnovno cepljenje odložiti do starosti 12 tednov.
Where intravenous access is not readily available Abseamed may be administered subcutaneously.
Kjer intravenski dostop ni takoj na razpolago, se zdravilo Biocrit lahko daje subkutano.
Where intravenous access is not readily available Binocrit may be administered subcutaneously.
Kjer intravenski dostop ni takoj na razpolago, se zdravilo Biocrit lahko daje subkutano.
Where intravenous access is not readily available Epoetin alfa HEXAL may be administered subcutaneously.
Kjer intravenski dostop ni takoj na razpolago, se zdravilo Biocrit lahko daje subkutano.
Where necessary, wash the teats thoroughly with warm water containing a suitable dairy cleansing agent and dry them thoroughly.
Kadar je treba, temeljito operite vime s toplo vodo, ki vsebuje primerno čistilno sredstvo (namenjeno čiščenju vimena) in ga nato temeljito osušite.
Where P is the maximum output power rating of the transmitter in watts (W) according to the transmitter manufacturer and d is the recommended separation distance in meters (m).
Kjer je P največja izhodna moč oddajnika, merjena v wattih (W), po proizvajalčevi oceni in je d priporočena razdalja v metrih (m).
Where patients are receiving several inhaled medicinal products and chest physiotherapy, it is recommended that Vantobra is used last.
Pri bolnikih, ki uporabljajo več različnih inhalacijskih zdravil in metod dihalne fizioterapije, je priporočljivo, da vzamejo zdravilo Vantobra kot zadnje.
Where practical, surgical manipulations to the site should be completed prior to product implantation.
Če je mogoče, končajte kirurške posege na tem mestu pred vsaditvijo zdravila.
Where should I give my injection?
Kam si boste vbrizgali zdravilo?
Where should you give your injection?
Kam naj si daste injekcijo?
Where the child’s specific needs determine that co-administration with food is required, dosing of the medicinal product should be consistently performed during food intake.
Če je treba zaradi posebnih otrokovih potreb zdravilo jemati s hrano, je treba zdravilo dosledno jemati med obrokom.
Where the combination cannot be avoided patients should be closely monitored.
Če se kombinaciji ni mogoče izogniti, je potrebno bolnike skrbno nadzirati.
Where the dose calculated is not a multiple of 50, the nearest dose below the maximum of 15mg/kg/day should be selected, provided that is sufficient to suppress urinary bile acids.
Kadar izračunani odmerek ni večkratnik števila 50, je treba izbrati najbližji odmerek pod največjim odmerkom 15 mg/kg/dan, če je to zadostno za zaviranje žolčnih kislin v urinu.
where the fracture is disease-related (such as metabolic bone disease or cancer);
osebe, pri katerih je zlom povezan z boleznijo (npr. presnovnimi boleznimi ali rakom);
Where the results of the test(s) strongly suggest resistance to a particular anthelmintic, an anthelmintic belonging to another pharmacological class and having a different mode of action should be used.
Če rezultati testov jasno kažejo na odpornost na določen antihelmintik, je treba uporabiti antihelmintik iz drugega farmakološkega razreda z drugačnim načinom delovanja.
where the skin or lesion is not broken;
kjer koža oz. lezija ni počila,
where the surrounding skin is not swollen; or if your doctor thinks that other treatments are not suitable for you.
kjer koža v okolici ni otekla in, če vaš zdravnik meni, da druge oblike zdravljenja za vas niso primerne.
Where there is maternal transmission of HBV, despite adequate prophylaxis, consideration should be given to discontinuing breastfeeding to reduce the risk of the emergence of lamivudine resistant mutants in the infant.
V primeru prenosa HBV z matere na otroka, kljub ustrezni profilaksi pride v poštev prenehanje dojenja, da bi pri dojenčku zmanjšali tveganje pojava proti lamivudinu odpornih mutantov.
Where thrombocytopenia caused by heparin use is suspected, platelet aggregation tests carried out in vitro have limited diagnostic value.
Pri sumu na trombocitopenijo zaradi heparina imajo pri bolnikih testi agregacije trombocitov in vitro omejeno diagnostično vrednost.
Where to apply your Rivastigmine 3M Health Care Ltd. transdermal patch
Kam namestiti transdermalni obliž Rivastigmin 3M Health Care Ltd.
WHERE TO GIVE YOURSELF THE INJECTION
IZBIRANJE MESTA ZA INJICIRANJE
Where to stick the patch
Kam nalepiti obliž
whereas acid rapidly degrades didanosine which
želodčne kisline, pri čemer kislina hitro
Whereas anti-viral immune responses defend normal cells following infection by talimogene laherparepvec, tumours have been shown to be susceptible to injury and cell death from ICP34.5- deficient HSV-1 viruses, including talimogene laherparepvec.
Medtem ko protivirusni imunski odzivi po okužbi s talimogenom laherparepvekom branijo normalne celice, so tumorji dokazano občutljivi za poškodbo in celično smrt zaradi virusov HSV-1 brez ICP34.5, vključno s talimogenom laherparepvekom.
whereas caution should be used
(npr. ponedeljek-sreda-petek).
whereas caution should be used
Kombinacija lahko poveča
Whereas Intrinsa is indicated with concomitant estrogen therapy, the subgroup of patients receiving oral conjugated equine estrogens (CEE) did not demonstrate a significant improvement in sexual function.
Čeprav je zdravilo Intrinsa indicirano za sočasno zdravljenje z estrogenom, podskupina bolnic, ki so prejemale peroralne konjugirane konjske estrogene (CEE, conjugated equine estrogen), ni pokazala pomembnega izboljšanja spolne funkcije.
Whereas Livensa is indicated with concomitant estrogen therapy, the subgroup of patients receiving oral conjugated equine estrogens (CEE) did not demonstrate a significant improvement in sexual function.
Čeprav je zdravilo Livensa indicirano za sočasno zdravljenje z estrogenom, podskupina bolnic, ki so prejemale peroralne konjugirane konjske estrogene (CEE, conjugated equine estrogen), ni pokazala pomembnega izboljšanja spolne funkcije.
Whereas very high oral single doses of oseltamivir phosphate salt, up to the highest dose tested (1,310 mg/kg), had no adverse reactions in adult rats, such doses resulted in toxicity in juvenile 7-day- old rat pups, including death.
Medtem ko zelo veliki peroralni enkratni odmerki soli oseltamivirjevega fosfata, do najvišjega preizkušenega odmerka (1310 mg/kg), nimajo neželenih učinkov pri odraslih podganah, so taki odmerki povzročili zastrupitve pri mladih ,7 dni starih podganah, vključno s smrtjo.
Whereas very high oral single doses of oseltamivir phosphate salt, up to the highest dose tested (1,310 mg/kg), had no adverse reactions in adult rats, such doses resulted in toxicity in juvenile 7-day- old rat pups, including death.
Medtem ko zelo veliki peroralni enkratni odmerki soli oseltamivirjevega fosfata, do najvišjega preizkušenega odmerka (1310 mg/kg), nimajo neželenih učinkov pri odraslih podganah, so taki odmerki povzročili zastrupitve pri mladih, 7 dni starih podganah, vključno s smrtjo.
Wherever possible apply to undamaged skin.
Razmaknite dlako, da bo vidna koža.
Wherever possible, the illuminated area must extend beyond the tumour margin by a distance of 0.5 cm.
Obsevano območje mora obsegati, kjer je to mogoče, tudi področje 0,5 cm okoli roba tumorja.
Whether the increased risk observed was due to Parkinson’s disease or other factors, such as medicinal products used to treat Parkinson’s disease, is unclear.
Ni znano ali je povečano tveganje, ki so ga opazili, posledica Parkinsonove bolezni ali drugih dejavnikov, kot so npr. zdravila za zdravljenje Parkinsonove bolezni.
Whether the neurological disorders are transient or permanent is currently unknown.
Zaenkrat ni znano, ali so te nevrološke motnje prehodne ali trajne.
Whether this affected respiration during the night is unknown.
Ni znano ali je to vplivalo na dihanje ponoči.
Whether this also applies to 17β-estradiol-containing COCs remains to be confirmed.
Če to velja tudi za KPK, ki vsebujejo 17β-estradiol, je treba še potrditi.
whether you have anaemia (a reduced number of red blood cells) whether your liver is working properly
ali imate anemijo (zmanjšano število rdečih krvnih celic) ali vaša jetra pravilno delujejo
whether you have anaemia whether your liver is working properly.
če imate anemijo, če je delovanje jeter pravilno.
WHI Studies combined – Additional risk of ischaemic stroke* over 5 years use
Združene študije WHI – dodatno tveganje za ishemično možgansko kap* med 5-letno uporabo
WHI studies oestrogen only arm – additional risk of VTE over 5 years’ use
Študije WHI (skupina, ki je prejemala samo estrogen) – dodatno tveganje za VTE med 5-letno uporabo
which can result in virological failure and
tega lahko vodi v virološko neuspešnost in
Which information is still awaited for Bluevac BTV8?
Katere informacije o zdravilu Bluevac BTV8 še pričakujemo?
Which measures are being taken to ensure the safe use of Cystadane?
Kateri ukrepi se izvajajo za zagotovitev varne uporabe zdravila Cystadane?
Which measures are being taken to ensure the safe use of Omnitrope?
Kateri ukrepi se izvajajo za zagotovitev varne uporabe zdravila Omnitrope?
Which pack
Katero pakiranje
which was followed after surgery by additional cycles of adjuvant Herceptin (to complete 1 year of treatment)
po operaciji so sledili: dodatni cikli zdravila Herceptin, danega adjuvantno (do zaključitve prvega leta zdravljenja).
which was followed by
ledili so
which was followed by: carboplatin – at target AUC = 6 mg/mL/min administered by intravenous infusion over 30- 60 minutes repeated every 3 weeks for a total of six cycles
Temu je sledil: karboplatin (pri tarčni AUC 6 mg/ml/min) v obliki intravenske infuzije v 30 do 60 minutah, vsake 3 tedne, skupaj 6 ciklov.
While 5.8% and 3.9% of the subjects were positive for developing binding antibodies to romiplostim and TPO respectively, only 2 subjects (0.4%) were positive for neutralizing antibodies to romiplostim but these antibodies did not cross react with endogenous TPO.
Pozitiven izvid vezavnih protiteles proti romiplostimu je imelo 5,8% bolnikov in proti TPO 3,9% bolnikov, toda samo 2 bolnika (0,4%) sta imela pozitiven izvid nevtralizirajočih protiteles proti romiplostimu, vendar ta protitelesa niso navzkrižno reagirala z endogenim TPO.
While a baby is inside its mother’s womb it does not need to use its lungs.
V času, ko je otrok v maternici, ne uporablja svojih pljuč.
While absolute free active substance concentrations remain constant, the percent of free active substance will fluctuate directly with total active substance concentrations at steady-state go from Cmax,ss to Cmin,ss over the course of the dosing interval.
Medtem ko absolutne koncentracije proste učinkovine ostanejo konstantne, se tekom odmernega intervala odstotek proste učinkovine skladno s celokupno koncentracijo aktivne učinkovine v stanju dinamičnega ravnovesja spreminja od Cmax,ss do Cmin,ss.
While antibiotics, including Orbactiv, fight certain bacteria, they may not be active against other bacteria or fungi, which may therefore continue to grow.
Antibiotiki kot je Orbactiv uspešno zatirajo nekatere bakterije, proti drugim bakterijam ali glivam pa morda niso uspešni, zato lahko še naprej rastejo.
While being treated with IntronA, your doctor may want you to drink extra fluids to help prevent low blood pressure.
Medtem, ko prejemate zdravilo IntronA, vam bo zdravnik lahko naročil, da pijte več tekočine, da bi preprečili nizek krvni tlak.
While being treated with ReFacto AF, you should be monitored for the development of factor VIII inhibitors.
Med zdravljenjem z zdravilom ReFacto AF vas morajo spremljati glede razvoja inhibitorjev faktorja VIII;
While being treated with Viraferon, your doctor may want you to drink extra fluids to help prevent low blood pressure.
Medtem, ko prejemate zdravilo Viraferon vam bo vaš zdravnik lahko naročil, naj pijete več tekočine, da bi preprečili nizek krvni tlak.
While being treated with Voriconazole Hospira:
Med zdravljenjem z zdravilom Vorikonazol Hospira:
While being treated with Zoledronic Acid Hospira, you should maintain good oral hygiene (including regular teeth brushing) and receive routine dental check-ups.
V času zdravljenja z zdravilom Zoledronsks kislina Hospira morate skrbeti za dobro ustno higieno (kar vključuje redno čiščenje zob) in redno hoditi na rutinske preglede k zobozdravniku.
While both arms of the study received active therapy, the QoL data should be interpreted in the context of the open-label study design and therefore cautiously taken.
Obe skupini v študiji sta se zdravili z zdravilno učinkovino, vendar pa je podatke o kakovosti življenja treba interpretirati v kontekstu odprte zasnove študije in posledično razlagati previdno.
While both short- and long-term effectiveness of Latuda have been sufficiently demonstrated, the CHMP noted that in the short-term studies its effectiveness was found to be moderate.
Odbor CHMP je upošteval, da sta bili kratkoročna in dolgoročna učinkovitost zdravila Latuda zadovoljivo dokazani, vendar pa so kratkoročne študije pokazale zmerno učinkovitost zdravila.
While carefully holding the syringe and vial, swirl gently to mix the powder and water together.
Brizgo in vialo previdno držite ter ju nežno zavrtite, da se voda in prašek zmešata.
While certain patient subgroups are at an increased risk of major bleeding when treated with an anticoagulant, the excess bleeding risk for dabigatran is due to GI bleeding, typically seen within the first 3-6 months following initiation of dabigatran etexilate therapy.
Medtem ko se pri določenih podskupinah bolnikov med zdravljenjem z antikoagulantom poveča tveganje velikih krvavitev, k povečanju krvavitev pri uporabi dabigatrana prispevajo krvavitve v prebavilih, ki se značilno pojavljajo prve 3 do 6 mesecev po začetku zdravljenja z dabigatran eteksilatom.
While continuing to hold the skin, push the syringe plunger to inject the medicine while counting slowly to 10.
Medtem ko držite kožo, potisnite bat injekcijske brizge in si zdravilo injicirajte, med tem pa počasi štejte do 10.
While DAGT seroconversion in patients receiving Zavicefta was very common in clinical studies (the estimated range of seroconversion across Phase 3 studies was 3.2% to 20.8% in patients with a negative Coombs test at baseline and at least one follow-up test), there was no evidence of haemolysis in patients who developed a positive DAGT on treatment.
V kliničnih študijah je bila serokonverzija DAGT pri bolnikih, ki so prejemali zdravilo Zavicefta, zelo pogosta (ocenjeni razpon serokonverzij v študijah 3. faze je bil od 3,2 do 20,8 % pri bolnikih, ki so imeli izhodiščno negativen Coombsov test in vsaj še enega med spremljanjem), a pri bolnikih, ki se jim je med zdravljenjem pojavil pozitiven DAGT, ni bilo dokazov o hemolizi.
While dasabuvir is an in vitro inhibitor of P-gp, no significant change was observed in the exposure of the P-gp substrate, digoxin, when administered with Exviera with ombitasvir/paritaprevir/ritonavir.
Dasabuvir sicer in vitro zavira P-gp, vendar niso ugotovili pomembne spremembe izpostavljenosti substratu P-gp digoksinu, če je bil uporabljen skupaj z zdravilom Exviera in kombinacijo ombitasvir/paritaprevir/ritonavir.
While Econor cannot prevent the outbreak of the disease, it had a positive effect in terms of reducing the severity of disease and improving its outcome.
Čeprav zdravilo Econor ne more preprečiti izbruha bolezni, je imelo koristne učinke v smislu zmanjšanja resnosti bolezni in izboljšanja njenega izida.
While grade 3-4 neutropenia occurred in the randomised trial more frequently among Pixuvri recipients, it was uncomplicated in the majority of cases, noncumulative and associated with a low incidence of febrile neutropenia or infections.
V randomiziranih preskušanjih je bila nevtropenija 3.– 4. stopnje pogostejša pri bolnikih, ki so prejemali zdravilo Pixuvri, vendar v večini primerov ni bila zapletena, ni bila kumulativna in je bila povezana z majhno pogostnostjo febrilne nevtropenije ali okužb.
While heating proceed to step 4.
Med ogrevanjem nadaljujte s 4. korakom.
While holding the inhaler away from your mouth, breathe out as far as is comfortable.
Medtem ko inhalator držite odmaknjen od ust, izdihnite čim bolj globoko, a ne toliko, da bi bilo neprijetno.
While holding the inhaler away from your mouth, breathe out as far as is comfortable.
Medtem ko inhalator držite še odmaknjen od ust, izdihnite čim bolj globoko, a ne toliko, da bi bilo neprijetno.
While holding the needle and container in one hand, pick up the syringe and insert the syringe tip into the needle opening.
Medtem ko držite iglo z neodstranjenim delom embalaže v eni roki, z drugo roko primite brizgo ter vstavite konico brizge v odprtino igle.
While holding the needle cap, ensure the needle is firmly seated on the safety device with a push.
Medtem ko držite pokrovček igle, preverite, ali je igla čvrsto pritrjena na varnostnem pripomočku, tako da jo potisnete na stran.
While holding the pen upright with the needle cover uppermost, slowly turn the knob anticlockwise.
Peresnik držite pokonci s pokrovčkom igle, obrnjenim navzgor in počasi obračajte gumb v nasprotni smeri urinega kazalca.
While holding the pen with the needle pointing upwards, the insulin reservoir should be tapped with the finger so that any air bubbles rise up towards the needle.
Injekcijski peresnik je treba prijeti tako, da je igla obrnjena navzgor, in s prstom potrkati po insulinskem rezervoarju, da se morebitni zračni mehurčki dvignejo proti igli.
While holding the pen with the needle pointing upwards, the insulin reservoir should be tapped with the finger so that any air bubbles rise up towards the needle.
Podržite injekcijski peresnik tako, da je igla obrnjena navzgor, in s prstom potrkajte po insulinskem rezervoarju, da se bodo morebitni zračni mehurčki dvignili proti igli.
While holding the syringe upright, remove any air bubbles by slowly pushing on the plunger until the air is removed (see Diagram 16).
Brizgo obrnite navzgor in odstranite zrak iz nje tako, da počasi pritiskate na bat, dokler ni odstranjen ves zrak (glejte sliko 16).
While holding the top of the envelope bag out of the water, put it in a 37±1°C water bath being careful not to allow water to penetrate the seal.
Vrhnji konec ovojne vreče držite nad vodo, medtem ko jo vstavite v vodno kopel temperature 37 ± 1 °C; pazite, da voda ne prodre skozi tesnilo.
While holding the vial adapter firmly, insert the syringe tip into the vial adapter and twist the syringe clockwise with one hand until firm.
Medtem ko trdno držite adapter za vialo, vstavite konico brizge v adapter za vialo in z eno roko brizgo zasučite v smeri urnega kazalca, dokler ni trdno nameščena.
While holding the vial in one hand, remove the plastic packaging from the vial adaptor (see Diagram 5).
Z eno roko še vedno držite vialo, z drugo pa odstranite plastično embalažo z adapterja (glejte sliko 5).
While holding the vial upright on the flat surface, push the plunger VERY SLOWLY until all the solvent is in the vial (see Diagram 8).
Medtem ko držite vialo pokonci na ravni površini, potiskajte bat brizge ZELO POČASI, dokler ni ves vehikel v viali.